Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study.
Leal GC, Souza-Marques B, Mello RP, Bandeira ID, Caliman-Fontes AT, Carneiro BA, Faria-Guimarães D, Guerreiro-Costa LNF, Jesus-Nunes AP, Silva SS, Lins-Silva DH, Fontes MA, Alves-Pereira R, Cordeiro V, Rugieri-Pacheco S, Santos-Lima C, Correia-Melo FS, Vieira F, Sanacora G, Lacerda ALT, Quarantini LC.
Leal GC, et al. Among authors: quarantini lc.
J Affect Disord. 2023 Jun 1;330:7-15. doi: 10.1016/j.jad.2023.02.151. Epub 2023 Mar 4.
J Affect Disord. 2023.
PMID: 36871913
Clinical Trial.